Identification |
Name: | 7,10,13,16-Docosatetraenamide,N-(2-hydroxyethyl)-, (7Z,10Z,13Z,16Z)- |
Synonyms: | 7,10,13,16-Docosatetraenamide,N-(2-hydroxyethyl)-, (all-Z)-; (all-Z)-N-(7,10,13,16-Docosatetraenoyl)ethanolamine |
CAS: | 150314-35-5 |
Molecular Formula: | C24H41 N O2 |
Molecular Weight: | 375.59 |
Molecular Structure: |
 |
Properties |
Biological Activity: | Potent endocannabinoid ( anandamide analog) that activates CB 1 receptors in microglia and binds to rat synaptosomal membranes (K I = 34.4 nM). Cannabimimetic in vivo . |
Safety Data |
|
 |